WhaleCreep
HomeFunds22nw, LP › Q1 2026

22nw, LP 13F holdings, Q1 2026

Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →

22nw, LP disclosed 16 US equity positions worth $145.9m in its Q1 2026 13F filing. The largest position was FSTR at 20.4% of the reported book, followed by NKTR and LFCR.

· Q2 2026 →

What did 22nw, LP own in Q1 2026? Top 16 positions

#StockSectorWeightValueSharesΔ sharesvs prior
1 FSTR FOSTER L B CO Industrials 20.4%$29.8m1,067,186
2 NKTR NEKTAR THERAPEUTICS Healthcare 13.9%$20.2m281,115
3 LFCR LIFECORE BIOMEDICAL INC Healthcare 12.9%$18.9m1,254
4 NSP INSPERITY INC Industrials 9.1%$13.3m493,000
5 MLYS MINERALYS THERAPEUTICS INC Healthcare 8.2%$12.0m444,325
6 SRI STONERIDGE INC Consumer Cyclical 8.2%$11.9m2,466,975
7 FOXF FOX FACTORY HLDG CORP Consumer Cyclical 7.7%$11.2m678,165
8 CULP CULP INC 3.5%$5.1m1,859,061
9 CMT CORE MOLDING TECHNOLOGIES IN 3.4%$5.0m222,738
10 RGNX REGENXBIO INC Healthcare 2.8%$4.1m492,759
11 UFI UNIFI INC Consumer Cyclical 2.1%$3.0m852,455
12 TISI TEAM INC 1.9%$2.7m170,187
13 RZLT REZOLUTE INC 1.7%$2.5m820,653
14 FB1 FARMER BROS CO 1.7%$2.5m1,955,526
15 ELDN ELEDON PHARMACEUTICALS INC 1.3%$2.0m636,364
16 PHENIXFIN CORP 1.2%$1.7m43,115

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.